Pylarify f-18 injections
Active Awarded Last action
- Contract number
- 36C24626N0890
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,212,530
Award facts
- Contract value 100% obligated
- $1,212,529.92 Current and potential, with all options
- Completion date 19% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,212,530 |
About this award
Veterans Integrated Service Network 6 issued a BPA call to Progenics Pharmaceuticals Inc. for PYLARIFY F-18 injections with a ceiling value of $1,212,529.92, awarded August 20, 2026, and completing August 19, 2027. The call is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA master contract. Performance occurs at North Billerica, Massachusetts. PYLARIFY is a radiopharmaceutical diagnostic imaging agent for positron emission tomography scans used to detect and localize prostate cancer. The call carries firm fixed-price pricing with no set-aside designation.
Quick answers
Who was awarded contract 36C24626N0890?
36C24626N0890 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on August 20, 2026.
How much is contract 36C24626N0890 worth?
The government has obligated $1,212,530 on 36C24626N0890.
Is contract 36C24626N0890 an order under another contract?
Yes. 36C24626N0890 is a BPA call under 36F79725D0093-36C24626A0027, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0890 competed?
The extent of competition for 36C24626N0890 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award